Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10258637 Pharmaceutical composition, methods for treating and uses thereof

Patent 10258637 was granted and assigned to Boehringer Ingelheim on April, 2019 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Boehringer Ingelheim

Current Assignee

Boehringer Ingelheim

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

April 16, 2019

Patent Application Number

15918401

Date Filed

March 12, 2018

Patent Citations Received

US Patent 12115179 Pharmaceutical composition, methods for treating and uses thereof

0

US Patent 11666590 Pharmaceutical composition, methods for treating and uses thereof

0

US Patent 11833166 Pharmaceutical composition, methods for treating and uses thereof

0

US Patent 11918596 Pharmaceutical composition, methods for treating and uses thereof

0

US Patent 10398654 Pharmaceutical compositions

US Patent 10406172 Pharmaceutical composition, methods for treating and uses thereof

US Patent 10442795 Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein

US Patent 10596120 Pharmaceutical compositions

...

Patent Primary Examiner

Traviss C Mcintosh, III

Patent abstract

The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing metabolic disorders, such as type 1 or type 2 diabetes mellitus or pre-diabetes, in patients with renal impairment or chronic kidney disease (CKD).

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10258637 Pharmaceutical composition, methods for treating and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool